A Bipartisan Coalition of 47 Attorneys General Call on the FCC to Strengthen the Robocall Mitigation Database

To strengthen the Robocall Mitigation Database (RMD) so that providers understand what information they need to submit and have deadlines to submit this information

Read More →

Bipartisan coalition of attorneys general call for Congress to require surgeon general warning on social media platforms

The National Association of Attorneys General (NAAG) sent a letter to Congress calling on lawmakers to pass legislation requiring a U.S. surgeon general warning on all algorithm-driven social media platforms. The letter comes amidst growing scrutiny of social media companies for their role in generational harm to young people’s mental health.

Read More →

Coalition of 43 States Urges FTC to Strengthen Online Privacy and Safety Protections for America’s Youth

The National Association of Attorneys General (NAAG) sent a letter to the Federal Trade Commission (FTC) on behalf of a bipartisan coalition of 43 state attorneys general to urge the federal government to update and strengthen the rules technology companies must follow under the federal Children’s Online Privacy Protection Act (COPPA). Among other things, the…

Read More →

41 Attorneys General Call On Meta To Protect Users’ Accounts From Scammers

The National Association of Attorneys General (NAAG) sent a letter to Meta Platforms, Inc. (Meta) on behalf of a bipartisan coalition of 41 attorneys general that addresses the recent rise of Facebook and Instagram platform account takeovers by scammers and frauds. Account takeovers are when bad actors break into a user’s account and change passwords,…

Read More →

A Bipartisan Coalition of 39 State Attorneys General Urge Congressional Action on Pharmacy Benefit Manager Reform

The National Association of Attorneys General (NAAG) sent a letter to Congressional leaders on behalf of 39 attorneys general who urge congressional leaders to engage in meaningful debate and reform of the current practices of pharmacy benefit managers (PBMs) and to take decisive action to reform the way PBMs conduct business and bring more transparency…

Read More →

45 State Attorneys General Join in their Ongoing Efforts to Protect Consumers from Robocalls

A bi-partisan coalition of 45 state attorneys general sent a letter to the Federal Communications Commission (FCC) seeking to safeguard consumers from scam phone calls made by Voice-Over-Internet-Protocol (VoIP) service providers. The attorneys general submitted comments to the FCC on its proposal “to safeguard and secure the open Internet” (NPRM) asking it to clarify that…

Read More →

Bipartisan Coalition of Attorneys General Express Support for the G.U.A.R.D. VA Act

A bipartisan coalition of 44 attorneys general express support for the passage of legislative proposals included in Governing Unaccredited Representatives Defrauding (G.U.A.R.D.) Veterans Affairs (VA) Benefits Act. In a letter to congressional leaders, the attorneys general explain that the passing of the bipartisan legislation would hold unaccredited and unregulated actors accountable for targeting and preying…

Read More →

Attorneys General Call on Congress to Pass the Combating Illicit Xylazine Act

A bipartisan coalition of 39 state and territory attorneys general called on leaders of Congress to pass the Combating Illicit Xylazine Act (H.R.1839/S.993). Xylazine is only approved by the U.S. Food and Drug Administration (FDA) as a veterinary medicine and in humans, it is known to depress breathing and heart rate, lower blood pressure, and…

Read More →

Connecticut et al. v. Teva Pharmaceuticals USA, Inc. et al., No. 2:19-cv-02407, (E.D. Pa. filed in MDL 05/30/2019)

44 plaintiff states filed suit against Teva Pharmaceuticals and 19 of the nation’s largest generic drug manufacturers alleging a broad conspiracy to artificially inflate and manipulate prices, reduce competition and unreasonably restrain trade for more than 100 different generic drugs. The lawsuit was originally Connecticut, was transferred to the MDL court in Pennsylvania.  The lawsuit…

Read More →

Connecticut, et al. v. Sandoz, et al., Case No. 20-cv-3539 (E.D. Pa. June 10, 2020), MDL 2724 (E.D. Pa.)

Plaintiff states filed a third lawsuit stemming from the ongoing antitrust investigation into a widespread conspiracy by generic drug manufacturers to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade for generic drugs sold across the United States. The complaint focuses on 80 topical generic drugs  and names 26 corporate Defendants and 10…

Read More →